​

Medtronic (MDT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MDT Stock Forecast

Medtronic stock forecast is as follows: an average price target of $95.40 (represents a 17.73% upside from MDT’s last price of $81.03) and a rating consensus of 'Hold', based on 18 wall street analysts offering a 1-year stock forecast.

MDT Price Target

The average price target for Medtronic (MDT) is $95.40 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $106.00 to $82.00. This represents a potential 17.73% upside from MDT's last price of $81.03.

MDT Analyst Ratings

Hold

According to 18 Wall Street analysts, Medtronic's rating consensus is 'Hold'. The analyst rating breakdown for MDT stock is 0 'Strong Buy' (0.00%), 8 'Buy' (44.44%), 9 'Hold' (50.00%), 1 'Sell' (5.56%), and 0 'Strong Sell' (0.00%).

Medtronic Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 15, 2024David RescottRobert W. Baird$96.00$90.016.65%18.47%
Oct 10, 2024Shagun SinghRBC Capital$105.00$88.3518.85%29.58%
Oct 01, 2024Vijay KumarEvercore ISI$104.00$90.0315.52%28.35%
Oct 01, 2024Joanne WuenschCitigroup$92.00$90.032.19%13.54%
Aug 21, 2024David RomanGoldman Sachs$82.00$86.40-5.09%1.20%
Aug 21, 2024Steven LichtmanOppenheimer$94.00$86.468.72%16.01%
Aug 21, 2024Matt O'BrienPiper Sandler$90.00$85.385.41%11.07%
Aug 21, 2024Anthony PetroneMizuho Securities$98.00$86.3813.45%20.94%
Aug 21, 2024Larry BiegelsenWells Fargo$106.00$85.3824.15%30.82%
Aug 20, 2024Rick WiseStifel Nicolaus$87.00$85.381.90%7.37%
May 24, 2024David RescottRobert W. Baird$87.00$81.916.21%7.37%
May 24, 2024Shagun SinghRBC Capital$92.00$81.3813.05%13.54%
May 24, 2024Richard NewitterTruist Financial$88.00$81.388.13%8.60%
May 24, 2024Larry BiegelsenWells Fargo$105.00$81.3829.02%29.58%
May 23, 2024Rick WiseStifel Nicolaus$100.00$81.3822.88%23.41%
Sep 13, 2023Larry BiegelsenWells Fargo$102.00$80.9825.96%25.88%
Aug 10, 2023David RescottRobert W. Baird$90.00$82.948.51%11.07%
Jul 12, 2023Larry BiegelsenWells Fargo$100.00$87.2914.56%23.41%
Jan 09, 2023RBC Capital$89.00$80.8610.07%9.84%
Nov 30, 2022Wells Fargo$77.00$76.490.67%-4.97%
Nov 25, 2022Barclays$85.00$79.127.43%4.90%
Nov 23, 2022Cecilia FurlongMorgan Stanley$88.00$78.5312.06%8.60%
Nov 23, 2022Pito ChickeringDeutsche Bank$80.00$78.531.87%-1.27%
Nov 23, 2022RBC Capital$102.00$78.8429.37%25.88%
Nov 23, 2022Oppenheimer$85.00$77.979.02%4.90%
Nov 23, 2022Citigroup$85.00$77.939.07%4.90%
Nov 16, 2022Pito ChickeringDeutsche Bank$85.00$83.401.92%4.90%
Sep 07, 2022RBC Capital$110.00$86.0427.85%35.75%
Aug 24, 2022Morgan Stanley$101.00$89.3113.08%24.65%
Aug 24, 2022Larry BiegelsenWells Fargo$96.00$90.226.41%18.47%
Jul 20, 2022Truist Financial$97.00$88.909.11%19.71%
Jul 18, 2022Stifel Nicolaus$105.00$88.9418.06%29.58%
Jul 15, 2022Morgan Stanley$103.00$89.0315.68%27.11%
Jun 07, 2022Morgan Stanley$114.00$95.8418.94%40.69%
May 31, 2022Truist Financial$111.00$100.0310.97%36.99%
May 31, 2022Raymond James$109.00$99.0810.01%34.52%
May 27, 2022Cowen & Co.$117.00$97.3720.16%44.39%
May 27, 2022RBC Capital$122.00$98.2724.15%50.56%
May 27, 2022Deutsche Bank$121.00$98.2523.16%49.33%
May 27, 2022Morgan Stanley$115.00$98.2517.05%41.92%
May 27, 2022Citigroup$117.00$98.6018.66%44.39%
May 27, 2022Shagun Singh ChadhaRBC Capital$122.00$99.0823.13%50.56%
May 27, 2022Josh JenningsCowen & Co.$117.00$99.0818.09%44.39%
May 23, 2022Cowen & Co.$125.00$104.1120.06%54.26%
Mar 03, 2022Travis SteedBank of America Securities$135.00$107.6525.41%66.60%
Feb 26, 2022Michael MatsonNeedham$124.00$105.8417.16%53.03%
Feb 18, 2022Jayson BedfordRaymond James$116.00$99.9816.02%43.16%
Feb 16, 2022Matthew O'BrienPiper Sandler$105.00$102.542.40%29.58%
Jan 19, 2022Joanne WuenschCitigroup$129.00$107.1220.43%59.20%
Jan 16, 2022Matt O’BrienPiper Sandler$110.00$108.551.34%35.75%
Jan 07, 2022Cecilia FurlongMorgan Stanley$120.00$104.5414.79%48.09%
Dec 21, 2021David RescottTruist Financial$124.00$101.0522.71%53.03%
Dec 17, 2021Robbie MarcusJ.P. Morgan$105.00$99.405.63%29.58%
Dec 16, 2021Larry BiegelsenWells Fargo$110.00$100.968.95%35.75%
Dec 16, 2021Matthew TaylorUBS$135.00$100.9633.72%66.60%
Nov 24, 2021Christopher PasqualeGuggenheim$142.00$113.0425.62%75.24%
Nov 23, 2021Anthony PetroneJefferies$155.00$111.9938.41%91.29%
Aug 27, 2021David ToungArgus Research$165.00$131.5325.45%103.63%
Jun 10, 2021Josh JenningsCowen & Co.$141.00$122.0015.57%74.01%

The latest Medtronic stock forecast, released on Oct 15, 2024 by David Rescott from Robert W. Baird, set a price target of $96.00, which represents a 6.65% increase from the stock price at the time of the forecast ($90.01), and a 18.47% increase from MDT last price ($81.03).

Medtronic Price Target by Period

1M3M12M
# Anlaysts-415
Avg Price Target-$99.25$95.07
Last Closing Price$81.03$81.03$81.03
Upside/Downside-100.00%22.49%17.33%

In the current month, the average price target of Medtronic stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Medtronic's last price of $81.03. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Nov 19, 2024NeedhamHoldHoldHold
Oct 10, 2024RBC CapitalSector PerformOutperformUpgrade
Oct 08, 2024Wells FargoSector PerformSector PerformHold
Oct 08, 2024UBSUnderperformUnderperformHold
Oct 08, 2024RBC CapitalSector PerformSector PerformHold
Oct 01, 2024Evercore ISIOutperformOutperformHold
Oct 01, 2024CitigroupNeutralNeutralHold
Sep 12, 2024Piper SandlerNeutralNeutralHold
Aug 22, 2024BarclaysOverweightOverweightHold
Aug 21, 2024OppenheimerPerformPerformHold
Aug 21, 2024Piper SandlerOverweightOverweightHold
Aug 21, 2024Goldman SachsSellSellHold
Aug 21, 2024Piper SandlerNeutralNeutralHold
Aug 21, 2024Wells FargoOverweightOverweightHold
Aug 15, 2024Cowen & Co.BuyBuyHold
Aug 15, 2024UBSUnderperformNeutralUpgrade
Aug 12, 2024Wells FargoSector PerformSector PerformHold
Jul 16, 2024Wells FargoSector PerformSector PerformHold
Jul 16, 2024UBSUnderperformUnderperformHold
Jul 15, 2024Wells FargoOverweightOverweightHold
May 30, 2024Goldman SachsBuySellInitialise
May 24, 2024Wells FargoSector PerformSector PerformHold
May 24, 2024Cowen & Co.BuyBuyHold
May 24, 2024RBC CapitalSector PerformSector PerformHold
May 24, 2024Wells FargoOverweightOverweightHold
May 24, 2024UBSSellSellHold
May 23, 2024BTIGNeutralNeutralHold
Mar 13, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Mar 13, 2024OppenheimerPerformPerformHold
Mar 01, 2024RBC CapitalOutperformOutperformHold
Jan 12, 2024RBC CapitalSector PerformSector PerformHold
Sep 13, 2023Wells FargoOverweightOverweightHold
Aug 24, 2023NeedhamHoldHoldHold
Aug 23, 2023William BlairMarket PerformMarket PerformHold
Aug 22, 2023BernsteinOutperformOutperformHold
Jul 12, 2023SVB LeerinkOutperformOutperformHold
Jun 30, 2023WedbushOutperformInitialise
Jun 30, 2023CitigroupNeutralBuyInitialise
Jun 30, 2023RBC CapitalSector PerformOutperformInitialise
Jun 30, 2023Goldman SachsBuyInitialise
Apr 24, 2023BarclaysEqual-WeightOverweightUpgrade
Apr 24, 2023Wells FargoEqual-WeightOverweightUpgrade
Mar 10, 2023SVB LeerinkMarket PerformMarket PerformHold
Jan 09, 2023RBC CapitalOutperformSector PerformDowngrade
Nov 30, 2022Wells FargoEqual-WeightEqual-WeightHold
Nov 25, 2022BarclaysEqual-WeightEqual-WeightHold
Nov 23, 2022RBC CapitalOutperformOutperformHold
Nov 23, 2022OppenheimerPerformDowngrade
Nov 23, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Nov 23, 2022CitigroupBuyNeutralDowngrade
Nov 16, 2022Deutsche BankBuyHoldDowngrade
Sep 07, 2022RBC CapitalOutperformOutperformHold
Aug 24, 2022CitigroupBuyBuyHold
Aug 24, 2022Raymond JamesOutperformMarket PerformDowngrade
Aug 24, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Aug 24, 2022Wells FargoEqual-WeightEqual-WeightHold
Jul 15, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Jul 05, 2022Wolfe ResearchUnderperformInitialise
May 31, 2022Raymond JamesOutperformOutperformHold
May 27, 2022RBC CapitalOutperformOutperformHold
May 27, 2022Deutsche BankBuyBuyHold
May 27, 2022Morgan StanleyEqual-WeightEqual-WeightHold
May 23, 2022Cowen & Co.OutperformOutperformHold
May 17, 2022CitigroupBuyBuyHold
Feb 23, 2022Credit SuisseOutperformOutperformHold
Feb 23, 2022NeedhamBuyBuyHold
Feb 18, 2022Raymond JamesOutperformOutperformHold
Feb 17, 2022Piper SandlerNeutralNeutralHold
Jan 16, 2022Piper SandlerNeutralNeutralHold
Jan 09, 2022Morgan StanleyEqual-WeightDowngrade

Medtronic's last stock rating was published by Needham on Nov 19, 2024. The company gave MDT a "Hold" rating, the same as its previous rate.

Medtronic Financial Forecast

Medtronic Revenue Forecast

Apr 28Jan 28Oct 27Jul 27Apr 27Jan 27Oct 26Jul 26Apr 26Jan 26Oct 25Jul 25Apr 25Jan 25Oct 24Jul 24Apr 24Jan 24Oct 23Jul 23Apr 23Jan 23Oct 22Jul 22Apr 22Jan 22Oct 21Jul 21Apr 21Jan 21
Revenue-----------------$8.09B$7.98B$7.70B$8.54B$7.73B$7.58B$7.37B$8.09B$7.76B$7.85B$7.99B$8.19B$7.78B
Avg Forecast$10.29B$9.72B$9.60B$9.30B$9.68B$9.11B$9.15B$8.71B$9.28B$8.73B$8.74B$8.34B$8.86B$8.33B$8.27B$7.90B$8.45B$7.95B$7.93B$7.57B$8.25B$7.54B$7.70B$7.22B$8.43B$7.88B$7.96B$7.87B$8.14B$7.77B
High Forecast$10.37B$9.79B$9.67B$9.37B$9.75B$9.18B$9.22B$8.78B$9.35B$8.79B$8.81B$8.40B$8.93B$8.39B$8.30B$7.90B$8.45B$8.01B$7.97B$7.62B$8.32B$7.60B$7.79B$7.30B$8.53B$7.98B$8.06B$7.96B$8.23B$7.87B
Low Forecast$10.25B$9.68B$9.56B$9.26B$9.64B$9.08B$9.12B$8.68B$9.24B$8.69B$8.71B$8.30B$8.83B$8.30B$8.22B$7.90B$8.45B$7.92B$7.86B$7.54B$8.22B$7.51B$7.65B$7.17B$8.37B$7.83B$7.91B$7.82B$8.08B$7.72B
# Analysts89991299149915891819999189914810168139913
Surprise %-----------------1.02%1.01%1.02%1.04%1.02%0.99%1.02%0.96%0.98%0.99%1.01%1.01%1.00%

Medtronic's average Quarter revenue forecast for Apr 24 based on 9 analysts is $8.45B, with a low forecast of $8.45B, and a high forecast of $8.45B. MDT's average Quarter revenue forecast represents a 4.47% increase compared to the company's last Quarter revenue of $8.09B (Jan 24).

Medtronic EBITDA Forecast

Apr 28Jan 28Oct 27Jul 27Apr 27Jan 27Oct 26Jul 26Apr 26Jan 26Oct 25Jul 25Apr 25Jan 25Oct 24Jul 24Apr 24Jan 24Oct 23Jul 23Apr 23Jan 23Oct 22Jul 22Apr 22Jan 22Oct 21Jul 21Apr 21Jan 21
# Analysts89991299149915891819999189914810168139913
EBITDA-----------------$1.48B$2.27B$2.11B$2.68B$2.26B$2.21B$1.89B$2.46B$2.40B$2.30B$1.64B$2.39B$2.03B
Avg Forecast$2.82B$2.66B$2.63B$2.55B$2.65B$2.50B$2.51B$2.39B$2.54B$2.39B$2.39B$2.28B$2.43B$2.28B$2.27B$2.16B$2.88B$2.18B$2.17B$2.07B$2.62B$2.47B$2.12B$1.99B$2.38B$2.17B$2.20B$2.17B$1.78B$2.14B
High Forecast$2.84B$2.68B$2.65B$2.56B$2.67B$2.51B$2.52B$2.40B$2.56B$2.41B$2.41B$2.30B$2.44B$2.30B$2.27B$2.16B$3.45B$2.19B$2.18B$2.09B$3.14B$2.96B$2.15B$2.01B$2.85B$2.20B$2.22B$2.20B$2.14B$2.17B
Low Forecast$2.81B$2.65B$2.62B$2.54B$2.64B$2.49B$2.50B$2.38B$2.53B$2.38B$2.38B$2.27B$2.42B$2.27B$2.25B$2.16B$2.30B$2.17B$2.15B$2.06B$2.09B$1.98B$2.11B$1.98B$1.90B$2.16B$2.18B$2.16B$1.43B$2.13B
Surprise %-----------------0.68%1.05%1.02%1.03%0.91%1.04%0.95%1.04%1.10%1.05%0.75%1.34%0.95%

9 analysts predict MDT's average Quarter EBITDA for Apr 24 to be $2.88B, with a high of $3.45B and a low of $2.30B. This is 93.97% upper than Medtronic's previous annual EBITDA (Jan 24) of $1.48B.

Medtronic Net Income Forecast

Apr 28Jan 28Oct 27Jul 27Apr 27Jan 27Oct 26Jul 26Apr 26Jan 26Oct 25Jul 25Apr 25Jan 25Oct 24Jul 24Apr 24Jan 24Oct 23Jul 23Apr 23Jan 23Oct 22Jul 22Apr 22Jan 22Oct 21Jul 21Apr 21Jan 21
# Analysts89991299149915891819999189914810168139913
Net Income-----------------$1.32B$909.00M$791.00M$1.18B$1.22B$427.00M$929.00M$1.49B$1.48B$1.32B$763.00M$1.36B$1.27B
Avg Forecast----$2.29B$2.00B$1.92B$1.77B$2.13B$1.86B$1.81B$1.70B$2.07B$1.75B$1.61B$1.54B$1.78B$1.62B$1.52B$1.43B$1.62B$1.41B$1.66B$1.45B$1.47B$1.77B$1.67B$1.71B$1.12B$1.49B
High Forecast----$2.31B$2.02B$1.94B$1.78B$2.15B$1.88B$1.83B$1.72B$2.09B$1.77B$1.63B$1.54B$2.13B$1.64B$1.55B$1.48B$1.94B$1.69B$1.68B$1.47B$1.76B$1.80B$1.70B$1.74B$1.34B$1.52B
Low Forecast----$2.28B$1.99B$1.91B$1.76B$2.12B$1.85B$1.80B$1.69B$2.06B$1.74B$1.56B$1.54B$1.42B$1.62B$1.51B$1.37B$1.29B$1.13B$1.64B$1.43B$1.18B$1.76B$1.64B$1.70B$892.31M$1.48B
Surprise %-----------------0.81%0.60%0.55%0.73%0.87%0.26%0.64%1.01%0.84%0.79%0.45%1.22%0.85%

Medtronic's average Quarter net income forecast for Apr 24 is $1.78B, with a range of $1.42B to $2.13B. MDT's average Quarter net income forecast represents a 34.47% increase compared to the company's last Quarter net income of $1.32B (Jan 24).

Medtronic SG&A Forecast

Apr 28Jan 28Oct 27Jul 27Apr 27Jan 27Oct 26Jul 26Apr 26Jan 26Oct 25Jul 25Apr 25Jan 25Oct 24Jul 24Apr 24Jan 24Oct 23Jul 23Apr 23Jan 23Oct 22Jul 22Apr 22Jan 22Oct 21Jul 21Apr 21Jan 21
# Analysts89991299149915891819999189914810168139913
SG&A-----------------$2.67B$2.69B$2.61B$2.62B$2.62B$2.62B$2.57B$2.57B$2.56B$2.62B$2.55B$2.60B$2.54B
Avg Forecast$3.45B$3.26B$3.22B$3.12B$3.25B$3.06B$3.07B$2.92B$3.11B$2.93B$2.93B$2.80B$2.97B$2.79B$2.77B$2.65B$3.08B$2.67B$2.66B$2.54B$2.80B$2.81B$2.58B$2.41B$2.54B$2.64B$2.67B$2.63B$2.23B$2.60B
High Forecast$3.48B$3.28B$3.24B$3.14B$3.27B$3.08B$3.09B$2.94B$3.13B$2.95B$2.95B$2.82B$2.99B$2.81B$2.78B$2.65B$3.69B$2.69B$2.67B$2.56B$3.36B$3.37B$2.61B$2.44B$3.05B$2.67B$2.70B$2.67B$2.67B$2.63B
Low Forecast$3.44B$3.25B$3.21B$3.11B$3.23B$3.04B$3.06B$2.91B$3.10B$2.92B$2.92B$2.78B$2.96B$2.78B$2.76B$2.65B$2.46B$2.66B$2.63B$2.53B$2.24B$2.25B$2.56B$2.40B$2.03B$2.62B$2.65B$2.62B$1.78B$2.58B
Surprise %-----------------1.00%1.01%1.03%0.94%0.93%1.02%1.06%1.01%0.97%0.98%0.97%1.16%0.98%

Medtronic's average Quarter SG&A projection for Apr 24 is $3.08B, based on 9 Wall Street analysts, with a range of $2.46B to $3.69B. The forecast indicates a 15.08% rise compared to MDT last annual SG&A of $2.67B (Jan 24).

Medtronic EPS Forecast

Apr 28Jan 28Oct 27Jul 27Apr 27Jan 27Oct 26Jul 26Apr 26Jan 26Oct 25Jul 25Apr 25Jan 25Oct 24Jul 24Apr 24Jan 24Oct 23Jul 23Apr 23Jan 23Oct 22Jul 22Apr 22Jan 22Oct 21Jul 21Apr 21Jan 21
# Analysts89991299149915891819999189914810168139913
EPS-----------------$0.99$0.68$0.59$0.89$0.92$0.32$0.70$1.11$1.10$0.98$0.57$1.01$0.95
Avg Forecast----$1.78$1.55$1.49$1.37$1.65$1.44$1.40$1.32$1.61$1.36$1.25$1.20$1.45$1.26$1.18$1.11$1.55$1.27$1.28$1.12$1.56$1.37$1.29$1.32$1.42$1.15
High Forecast----$1.80$1.57$1.50$1.39$1.67$1.46$1.42$1.34$1.62$1.37$1.27$1.20$1.51$1.27$1.20$1.15$1.62$1.28$1.30$1.14$1.63$1.39$1.31$1.34$1.44$1.17
Low Forecast----$1.77$1.55$1.48$1.37$1.65$1.44$1.40$1.32$1.60$1.35$1.21$1.20$1.39$1.26$1.17$1.07$1.49$1.26$1.27$1.10$1.50$1.35$1.27$1.31$1.41$1.14
Surprise %-----------------0.78%0.58%0.53%0.57%0.72%0.25%0.62%0.71%0.81%0.76%0.43%0.71%0.83%

According to 9 Wall Street analysts, Medtronic's projected average Quarter EPS for Apr 24 is $1.45, with a low estimate of $1.39 and a high estimate of $1.51. This represents a 46.55% increase compared to MDT previous annual EPS of $0.99 (Jan 24).

Medtronic Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
TNDMTandem Diabetes Care$34.23$51.4350.25%Buy
DXCMDexCom$77.80$104.5034.32%Buy
MDTMedtronic$81.37$95.4017.24%Hold
ALGNAlign$228.81$264.1715.45%Buy
ZBHZimmer Biomet$108.06$121.7812.70%Hold
SYKStryker$370.81$408.3310.12%Buy
ABTAbbott Laboratories$113.29$120.096.00%Buy
EWEdwards Lifesciences$74.12$76.332.98%Buy
PODDInsulet$263.35$268.001.77%Buy

MDT Forecast FAQ

Is Medtronic a good buy?

No, according to 18 Wall Street analysts, Medtronic (MDT) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 44.44% of MDT's total ratings.

What is MDT's price target?

Medtronic (MDT) average price target is $95.4 with a range of $82 to $106, implying a 17.73% from its last price of $81.03. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Medtronic stock go up soon?

According to Wall Street analysts' prediction for MDT stock, the company can go up by 17.73% (from the last price of $81.03 to the average price target of $95.4), up by 30.82% based on the highest stock price target, and up by 1.20% based on the lowest stock price target.

Can Medtronic stock reach $120?

MDT's average twelve months analyst stock price target of $95.4 does not support the claim that Medtronic can reach $120 in the near future.

What are Medtronic's analysts' financial forecasts?

Medtronic's analysts financial forecasts for the fiscal year (Apr 2027) are as follows: average revenue is $36.66B (high $36.93B, low $36.52B), average EBITDA is $10.04B (high $10.11B, low $10B), average net income is $7.97B (high $8.05B, low $7.93B), average SG&A $12.29B (high $12.39B, low $12.25B), and average EPS is $6.19 (high $6.25, low $6.16). MDT's analysts financial forecasts for the fiscal year (Apr 2028) are as follows: average revenue is $38.92B (high $39.21B, low $38.76B), average EBITDA is $10.66B (high $10.73B, low $10.61B), average net income is $0 (high $0, low $0), average SG&A $13.05B (high $13.15B, low $13B), and average EPS is $0 (high $0, low $0).

Did the MDT's actual financial results beat the analysts' financial forecasts?

Based on Medtronic's last annual report (Apr 2023), the company's revenue was $31.23B, beating the average analysts forecast of $30.71B by 1.69%. Apple's EBITDA was $9.04B, missing the average prediction of $9.2B by -1.70%. The company's net income was $3.76B, missing the average estimation of $6.13B by -38.72%. Apple's SG&A was $10.42B, missing the average forecast of $10.6B by -1.72%. Lastly, the company's EPS was $2.85, missing the average prediction of $5.22 by -45.42%. In terms of the last quarterly report (Jan 2024), Medtronic's revenue was $8.09B, beating the average analysts' forecast of $7.95B by 1.71%. The company's EBITDA was $1.48B, missing the average prediction of $2.18B by -31.90%. Medtronic's net income was $1.32B, missing the average estimation of $1.62B by -18.57%. The company's SG&A was $2.67B, beating the average forecast of $2.67B by 0.23%. Lastly, the company's EPS was $0.99, missing the average prediction of $1.26 by -21.53%